Lamisil Dermgel (Terbinafine)

Terbinafine blocks the fungal enzyme squalene epoxidase, which is essential for producing ergosterol, a key component of the fungal cell membrane. Without ergosterol, toxic squalene accumulates, disrupting membrane integrity and leading to fungal cell death.

The dosage of Lamisil Dermgel is determined by the prescribing clinician based on the infection type, location and patient characteristics. The product is applied as a thin layer to the affected area once daily for the duration recommended by the healthcare professional.

Safety data for topical terbinafine in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil Dermgel.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azole topical agents, terbinafine has a different mechanism—blocking squalene epoxidase rather than inhibiting lanosterol 14α‑demethylase. This often results in a shorter treatment course and higher cure rates for dermatophyte infections, though individual response may vary.

Lamisil Dermgel should be stored at room temperature, below 25 °C. Keep the tube in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

Clean and dry the affected skin area, then apply a thin layer of the gel to the lesion and a small margin of surrounding skin. Rub gently until it disappears, and wash hands after application unless the hands are being treated.

Serious risks, though rare, include severe allergic reactions such as angioedema, widespread skin rash, Stevens‑Johnson syndrome, and systemic hypersensitivity. Patients should discontinue use and seek immediate medical attention if they experience swelling, blistering, or extensive rash.

Individuals with known hypersensitivity to terbinafine or any component of the gel should avoid its use. It should also not be applied to broken, inflamed or infected skin not caused by dermatophytes, and patients with uncontrolled systemic fungal infections should seek alternative therapy.